Bergan S - Search Results

1

Atorvastatin Metabolite Pattern in Skeletal Muscle and Blood from Patients with Coronary Heart Disease and Statin-Associated Muscle Symptoms.

Lauritzen T, Munkhaugen J, Peersen K, Kristiansen O, Sverre E, Nebauer SD, Villseth M, Andersen AM, Svarstad AC, Jensen EP, Bergan S, Husebye E, Vethe NT. Lauritzen T, et al. Among authors: bergan s. Clin Pharmacol Ther. 2023 Apr;113(4):887-895. doi: 10.1002/cpt.2844. Epub 2023 Feb 6. Clin Pharmacol Ther. 2023. PMID: 36622792 Clinical Trial.

2

[Immunosuppressive agents in organ transplantation].

Bergan S, Albrechtsen D, Bentdal O. Bergan S, et al. Tidsskr Nor Laegeforen. 1999 Oct 10;119(24):3615-20. Tidsskr Nor Laegeforen. 1999. PMID: 10563181 Review. Norwegian.

3

Calcineurin inhibitor-free immunosuppression in renal allograft recipients with thrombotic microangiopathy/hemolytic uremic syndrome.

Oyen O, Strøm EH, Midtvedt K, Bentdal O, Hartmann A, Bergan S, Pfeffer P, Brekke IB. Oyen O, et al. Among authors: bergan s. Am J Transplant. 2006 Feb;6(2):412-8. doi: 10.1111/j.1600-6143.2005.01184.x. Am J Transplant. 2006. PMID: 16426329 Free article.

4

Effects of DDT on paracetamol half-life in highly exposed mothers in Zimbabwe.

Chikuni O, Nhachi CF, Polder A, Bergan S, Nafstud I, Skaare JU. Chikuni O, et al. Among authors: bergan s. Toxicol Lett. 2002 Aug 5;134(1-3):147-53. doi: 10.1016/s0378-4274(02)00184-4. Toxicol Lett. 2002. PMID: 12191873

5

TDM: report concentration, Css, rather than area under the curve, AUC.

Bergan S. Bergan S. Ther Drug Monit. 2003 Dec;25(6):743. doi: 10.1097/00007691-200312000-00015. Ther Drug Monit. 2003. PMID: 14639063 No abstract available.

6

Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation.

Brunet M, Shipkova M, van Gelder T, Wieland E, Sommerer C, Budde K, Haufroid V, Christians U, López-Hoyos M, Barten MJ, Bergan S, Picard N, Millán López O, Marquet P, Hesselink DA, Noceti O, Pawinski T, Wallemacq P, Oellerich M. Brunet M, et al. Among authors: bergan s. Ther Drug Monit. 2016 Apr;38 Suppl 1:S1-20. doi: 10.1097/FTD.0000000000000287. Ther Drug Monit. 2016. PMID: 26977997 Review.

7

[Side effects of antitubercular drugs leading to discontinuation of drug therapy].

Bergan S, Laake K, Bjartveit K. Bergan S, et al. Tidsskr Nor Laegeforen. 1980 Feb 20;100(5):279-82. Tidsskr Nor Laegeforen. 1980. PMID: 7385151 Norwegian. No abstract available.

8

[Mycophenolate mofetil--a new immunosuppressive agent].

Bergan S, Albrechtsen D, Fauchald P. Bergan S, et al. Tidsskr Nor Laegeforen. 1996 Aug 30;116(20):2439-41. Tidsskr Nor Laegeforen. 1996. PMID: 8928103 Review. Norwegian.

9

C2 monitoring in maintenance renal transplant recipients: is it worthwhile?

Midtvedt K, Fauchald P, Bergan S, Høieggen A, Hallan S, Svarstad E, Bergrem H, Eriksen BO, Pfeffer PF, Dalen I, Leivestad T. Midtvedt K, et al. Among authors: bergan s. Transplantation. 2003 Oct 27;76(8):1236-8. doi: 10.1097/01.TP.0000085046.39523.D5. Transplantation. 2003. PMID: 14578761

10

[Better therapeutic potential for azathioprine and mercaptopurine].

Bergan S, Norge O. Bergan S, et al. Lakartidningen. 2000 Apr 19;97(16):1999-2000. Lakartidningen. 2000. PMID: 10826362 Norwegian. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters